CJCarolin Jethwa

Carolin Jethwa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Carolin Jethwa has a total of 54 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Real-time, macroscopic shortwave infrared Raman imaging for surgical and pre-clinical applications

    by Oliver Bruns, Bernardo Arús, Joycelyn Yiu, Julia Barthel, Simon Härtl, Julia Correa Remus, Rudi Apolle, Jakob Lingg, Anja Hofmann, Amy Fumo, et al.

    Optical imaging has transformed biomedical research and clinical practice by revealing tissue identity and function in living organisms and during surgery. In the shortwave infrared (SWIR, 1000-1700 nm), biological tissues exhibit lower scattering and autofluorescence, properties that improve penetration depth and image contrast. Raman scattering imaging is a label-free optical technique that provides chemical information across a wide range of applications, particularly at microscopic and mesoscopic scales. In biological tissues, however, macroscopic Raman imaging has remained challenging because, at visible and near-infrared wavelengths, autofluorescence overwhelms the weak Raman signals. Here we integrate the favorable optical properties of SWIR with the specificity of Raman scattering to establish SWIR Raman imaging for real-time, high-contrast chemical imaging across surgically relevant fields of view. We demonstrate its versatility by monitoring tissue dynamics in living animals, detecting fatty liver disease non-invasively in mice, and identifying calcification and lipids in human atherosclerotic plaques. In surgical settings, SWIR Raman reveals lymph nodes and nerves that are invisible otherwise, providing magnetic-resonance-imaging-like anatomical information directly in the operation field for real-time surgical guidance. SWIR Raman thereby expands the capabilities of optical imaging to applications requiring rapid biochemical identification over large tissue areas and can improve surgical decision-making and patient outcomes.

  • Mir147 Limits the Contribution of Non-Foamy Macrophages to Atherosclerosis

    by Nan Li, Khadijeh Taherdangkoo, Isabelle M. Baatsch, Tanya Guduru, Qiuxing Meng, Shilun Li, Yanyi Zhou, Xinwei Li, Mengyu Zhu, Sarah K. Polczer, et al.

    BACKGROUND: Hypercholesterolemia and a high-fat diet promote 2 macrophage subtypes involved in atherosclerosis by inducing lipid droplet accumulation in foamy macrophages (FMs) and triggering inflammatory activation in non-foamy macrophages (NFMs). MicroRNAs are key regulators of macrophage subtypes in atherosclerosis; for instance, miR-10a-5p limits lipid droplet formation, while miR-155-5p enhances inflammation. miR-147-3p is upregulated by inflammatory stimuli in macrophages and in atherosclerotic lesions, suggesting a potential role in NFMs. METHODS: The role of miR-147-3p in macrophages, with or without enhanced green fluorescent protein expression, in atherosclerosis was examined in Apoe –/– (apolipoprotein E-deficient) mice with a myeloid cell-specific knockout of the microRNA 147 ( Mir147 ) gene. Using live-plaque 4D confocal imaging, we assessed lipid droplets, caspase-3 activation, phagocytosis of apoptotic DNA, cholesterol crystal (CC) formation, mitochondrial function, macrophage migration, and tubular membrane extension formation. Green fluorescent protein-tAgo2 (tagged Argonaute 2) immunoprecipitation combined with prime RNA sequencing was performed using atherosclerotic aortas from Apoe –/– mice that expressed tAgo2 in myeloid cells. The effect of the galectin-3 inhibitor GB1107 was studied using 4D live-plaque imaging. RESULTS: Unlike FMs, NFMs are primarily located in the plaque core and show higher miR-147-3p levels in both mouse and human atherosclerosis. Knocking out Mir147 in myeloid cells increases atherosclerosis, with enhanced CC formation and apoptotic DNA accumulation in necrotic cores. Removing Mir147 reduces mitochondrial activity and elevates caspase-3 activity in NFMs, but not in FMs, and lowers the spare respiratory capacity of plaque macrophages. Moreover, deleting Mir147 impairs NFM uptake of apoptotic DNA, increases extracellular apoptotic DNA, and promotes CC formation. Additionally, Mir147 deficiency in NFMs induces caspase-3 activation in endothelial cells, facilitating the transendothelial extension of FM projections. The Lgals3 transcript, encoding galectin-3, was reduced in the tAgo2 immunoprecipitate after Mir147 knockout. A miR-147-3p binding site in the Lgals3 3’-UTR was functionally confirmed. GB1107 treatment reversed the Mir147 knockout effect in macrophages. CONCLUSIONS: miR-147-3p reduces atherosclerosis by suppressing the harmful effects of NFMs on endothelial cells and by enhancing their clearance of apoptotic DNA through targeting galectin-3. Increasing miR-147-3p levels might thus slow the expansion of the necrotic core and reduce atherothrombosis caused by NFM-induced endothelial damage.

  • Open Access

    Fuse your mitochondria, lose appetite: an anorexic, anti‐obesity sphingolipid

    by Carolin Muley, Alexander Bartelt

    Aberrant production of ceramides, the precursors of complex sphingolipids, is a hallmark of obesity and strongly linked to metabolic dysfunction (Meikle and Summers 2017). Ceramides are formed by recycling or de novo synthesis from sphingosine and a fatty acid side chain moiety. The side chain length determines lipotoxicity of ceramides, as those composed of C16:0 or C18:0 side chains are toxic whereas those with C24:0 or C24:1 are not (Meikle and Summers 2017). Counteracting the deleterious effects of high‐fat diets (HFDs) rich in saturated fat either by inhibiting synthesis or by promoting degradation of ceramides mitigates insulin resistance and ectopic lipid accumulation (Meikle and Summers 2017). However, drugs that safely and selectively target ceramide metabolism have failed to translate into metabolic benefit in human trials so far.